The Technical Analyst
Select Language :

CTI Biopharma Corp [CTIC]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

CTI Biopharma Corp is listed at the NASDAQ Exchange

5.98% $2.48

Last updated: 28 Nov 2021 @ 17:18 pm


FUNDAMENTALS
MarketCap: 239.80 mill
EPS: -0.902
P/E: 0.000
Earnings Date: Nov 12, 2021
SharesOutstanding: 96.69 mill
Avg Daily Volume: 0.875 mill
RATING 2021-11-26
B+
Neutral
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/203/204/201/212/213/21
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.000 | sector: PE 67.21
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE 0.000 | industry: PE 479.09
DISCOUNTED CASH FLOW VALUE
$3.05
(22.90%) $0.568
Date: 2021-11-28

Insider Trading

Date Person Action Amount type
2021-04-01 Bvf Partners L P/il Buy 1 044 813 Common Stock, par value $0.001
2021-04-01 Bvf Partners L P/il Buy 950 016 Common Stock, par value $0.001
2021-04-01 Bvf Partners L P/il Buy 5 171 Common Stock, par value $0.001
2021-04-01 Bvf Partners L P/il Buy 344 Series X1 Convertible Preferred Stock
2021-04-01 Bvf Partners L P/il Buy 239 Series X1 Convertible Preferred Stock
INSIDER POWER
67.87
Last 100 transactions
Buy: 28 923 375 | Sell: 7 096 677

Forecast: 14:40 - $2.49

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $2.48
Forecast 2: 14:00 - $2.49
Forecast 3: 14:40 - $2.49
SCORE
1.23
Buy
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.48 (5.98% )
Volume 1.588 mill
Avg. Vol. 0.875 mill
% of Avg. Vol 181.47 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for CTI Biopharma Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for CTI Biopharma Corp

RSI

Intraday RSI14 chart for CTI Biopharma Corp
The Live Chart for CTI Biopharma Corp
Profile picture for
            CTI Biopharma Corp

CTIC

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase III clinical trials for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was founded in 1991 and is headquartered in Seattle, Washington.

Last 10 Buy Signals
Date Signal @
BTCUSDNov 28 - 12:1654 220
XRPUSDNov 28 - 12:130.923
BTCUSDNov 28 - 12:1054 267
BTCUSDNov 28 - 12:0454 208
BTCUSDNov 28 - 12:0054 239
XRPUSDNov 28 - 12:000.921
XRPUSDNov 28 - 11:510.918
XRPUSDNov 28 - 11:440.914
BTCUSDNov 28 - 11:2954 102
DOGEUSDNov 28 - 11:29$0.198

Stock Peers

Company Price Change
CTIC2.485.98%
ADMA1.450-3.33%
BIVI6.141.49%
CDMOP25.060.04%
CMMB8.87-0.22%
CNTG6.91-4.03%
CRBP0.884-3.06%
KIN9.250.11%
LRMR10.12-3.89%
OBSV2.240.00%
ORPH3.30-2.94%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.